No Image found

Contact Information:
Carl K. Buckner



 

Buckner, Carl K. (HSC)
Professor (Retired)

Department of:

Center of:

Education:

The Ohio State University, Columbus   PhD (Pharmacology)   1970

Professional Interest/Expertise/Specializations:
In Dr. Houchen's early career his research focused upon the complex biology of RNA binding proteins in colon cancer.

Websites:

Research Projects:

Selected Publications:

Frontier entrepreneurs: The development of commercial pharmacy in Oklahoma - Part 4 - Early drug store owners and pharmacists in Muskogee. 76(4): 17-25
2008    Buckner CK.
Oklahoma Pharmacist
Oklahoma pharmacy at statehood: Part 4. Prohibition and the state dispensary system. 1.
2008    Buckner CK.
Oklahoma Pharmacist
Oklahoma Pharmacy at Statehood, Part 2 - Itinerant medicine vendors: Examples of the genre. 75(3).
2007    Buckner CK.
Oklahoma Pharmacist;
Indian Territory Pharmaceutical Association. Part II - Proceedings and Pursuits. 74 (No. 2) 22-29
2006    Buckner CK.
Oklahoma Pharmacist:
Indian Territory Pharmaceutical Association. Part 1 - Formation and Pharmacy Law-Related Endeavors. 19-24.
2006    Buckner CK.
Oklahoma Pharmacist, 74 (No. 1, 2006):
Antecedents of Pharmacy in Oklahoma. The Three Forks. Part 2 ¿ Domain, Devoutness, and Disease.
   Buckner CK.
Oklahoma Pharmacist, 72 (Fall, 2004): 17-21
Antecedents of Pharmacy in Oklahoma. The Three Forks. Part 1 ¿ Early Arrivals.
   Buckner CK.
Oklahoma Pharmacist, 72 (Summer, 2004): 17-21
The First Pharmacy Law of Oklahoma Territory.
   Buckner CK.
Oklahoma Pharmacist, 72 (Spring, 2004): 17-20
Production of a rabbit antibody specific to guinea pig (GP) IGE.
   Stahl J, Cook E, Buckner CK and Graziano FM
J. Allergy Clin. Immunol. 93: 244, 1994
The First Oklahoma Territory Board of Pharmacy. I. Beginning Events.
   Buckner CK.
Oklahoma Pharmacist 71: (Summer, 2003): 10-12
Pharmacological examination of the neurokinin-1 receptor mediating relaxation of human intralobar pulmonary artery.
   Pedersen KE, Buckner CK, Meeker Sonya N, Undem BJ.
J Pharmacol Exp Ther 2000; 292: 319-325
Pharmacology of ZM274773: A selective and orally active, nonpeptide neurokinin-A (NK2) receptor antagonist.
   Rumsey W, Aharony D, Buckner CK, Graham A, Undem B, McCarthy M, Kusner E, Barthlow H, Siddiqui K, Ghanekar S, Kays J, Lengel D, Powell S, Meeker S and Miller S.
FASEB J.,
The Students. In: University of Wisconsin School of Pharmacy ¿ Its First Century, ed. by G. Sonnedecker,
   Buckner CK.
University Publications, Madison, 1997
Effects of antigen challenge on the NANC contractions of the guinea pig hilar bronchus.
   Alkon JH and Buckner CK
FASEB J., 1996
Pharmacological characterization of a novel class of non-peptide neurokinin A antagonists that demonstrate species selectivity.
   Aharony D, Buckner CK, Ellis JL, Ghanekar SV, Graham A, Kays J S, Little J, Meeker S, Miller SC, Undem BJ and Waldron IR
Abs. of Tachykinins '95 Meeting, Florence, 1995
A comparison of the effects of isoproterenol and forskolin on immunologic and non-immunologic release of histamine from guinea-pig superfused trachea and dispersed tracheal cells.
   Buckner CK, Fishleder RI, Conklin R, Graziano FM
J Pharmacol Toxicol Meth 1995; 33: 47-52
Pharmacological characterization of a new class of nonpeptide neurokinin A antagonists that demonstrate species selectivity.
   Aharony D, Buckner CK, Ellis JL, Ghanekar SV, Graham A, Kays JS, Little J, Meeker S, Miller SC, Undem BJ. and Waldron IR.
J Pharmacol Exp Ther 1995; 274: 1216-1221
Synthesis, structure-activity relationships, and pharmacological evaluation of a series of fluorinated 3-benzyl-5-indolecarboxamides: Identification of 4-[[5-[((2R)-2-methyl-4,4,4-trifluorobutyl)carbamoyl]-1-methylindol-3-yl]methyl]-3-methoxy-N-[(2-methylphenyl)sulfonyl]benzamide, a potent, orally active antagonist of leukotrienes D4 and E4.
   Jacobs RT, Bernstein PR, Cronk LA, Vacek EP, Newcomb LF, Aharony D, Buckner CK, Kusner EJ
J Med Chem 1994; 37: 1282-1297
Preclinical exploration of the potential anti-inflammatory properties of the peptide leukotriene antagonist ICI 204,219 (Accolate).
   Krell RD, DeHaas CJ, Lengel DJ, Kusner EJ, Williams JC, Buckner CK.
Ann NY Acad Sci 1994; 744: 289-298
Peptidoleukotriene release from guinea-pig lung mast cells.
   Doran O, Stahl J, Cook E, Buckner CK, Graziano FM.
Inflammation 1994; 18: 89-97
The 5-lipoxygenase inhibitors ZD2138 and ZM230487 are potent and selective inhibitors of several antigen-induced guinea-pig pulmonary responses.
   Kusner EJ, Buckner CK, Dea DM, DeHaas CJ, Marks RL, Krell RD.
Eur J Pharmacol 1994; 257: 285-292
The Organization of Pharmacy in Oklahoma Territory.
   Buckner CK.
Oklahoma Pharmacist 72 (Winter, 2004): 13-16
Frontier Entrepreneurs. The Development of Commercial Pharmacy in Oklahoma. Part 1 - Traders and General Merchants.
   Buckner CK.
Oklahoma Pharmacist, 73 (Spring, 2005): 17-22
Frontier Entrepreneurs. The Development of Commercial Pharmacy in Oklahoma. Part 2 - Physicians in the Choctaw Nation.
   Buckner CK.
Oklahoma Pharmacist, 73 (Summer, 2005): 23-28
Frontier Entrepreneurs. The Development of Commercial Pharmacy in Oklahoma. Part 3 - Early Drug Store Owners in the Lineage of Osborn Drugs in Vinita.
   Buckner CK.
Oklahoma Pharmacist, 73 (Fall, 2005): 17-24
Antecedents of Pharmacy in Oklahoma. The Three Forks. Part 3 ¿ Marcus Palmer and the Healing Arts.
   Buckner CK.
Oklahoma Pharmacist, 73 (Winter, 2005): 19-23
The First Oklahoma Territory Board of Pharmacy. II. The Eight Day Session.
   Buckner CK.
Oklahoma Pharmacist 71 (Fall, 2003): 10-14
Keywords, Tags: